Format

Send to

Choose Destination
Haematologica. 2017 Sep;102(9):e348-e351. doi: 10.3324/haematol.2017.167254. Epub 2017 May 11.

Combining flow cytometry and WT1 assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia.

Author information

1
Clinic of Hematology, Department of internal medicine (DIMI), University of Genoa, IRCCS AOU San Martino-IST, Genoa, Italy fabio.guolo21@gmail.com.
2
Clinic of Hematology, Department of internal medicine (DIMI), University of Genoa, IRCCS AOU San Martino-IST, Genoa, Italy.
3
Division of Hematology and Bone Marrow Transplantation, IRCCS AOU San Martino-IST, Genoa, Italy.
4
Clinical Flow Cytometry Unit, Department of Pathology, IRCCS AOU San Martino-IST, Genoa, Italy.
5
Istituto di Ematologia, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A Gemelli, Rome, Italy.
PMID:
28495917
PMCID:
PMC5685236
DOI:
10.3324/haematol.2017.167254
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center